Clinical Trials Browser

Withdrawn × INDUSTRY × tocilizumab × Clear all

NCT06372574 2024-09-03

A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors

Phase 1 Withdrawn

Neoplasms, Recurrence